← Back

Mitsui Chemicals | 321Catalyst

corporate vc$60MCo-invests

◆ Fund Size

$60M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

◆ Share this fund

◆ Investment Thesis

Targets new materials and technology partnerships to deepen ICT Solutions and specialty businesses, seeking to rely less on volatile naphtha-linked operations.

◆ About Mitsui Chemicals

321Catalyst is a $60 million corporate venture capital fund established by Mitsui Chemicals to accelerate global innovation partnerships and launch new products and businesses. The fund invests in startups across seed stage and beyond, focusing on sectors including mobility, healthcare, IT, sustainability, and other emerging industries globally.

◆ Sectors

Advanced MaterialsSustainable Materials

◆ Stages

seedseries-a

◆ Geography Focus

AsiaEuropeGlobalUnited States

◆ Team

NameTitleRoleLinks
Shunsuke FujiiPresident—

◆ Notable Investments

RLWRLDAIO CoreMonoxerLaboro.AINearMeHoxton FarmsNuMat TechnologiesSharing EnergyRegCellMateria BioworksShoulder Innovations Inc.

◆ Traits

Co-invests

◆ FAQ

What does 321Catalyst invest in?

321Catalyst invests in Advanced Materials and Sustainable Materials at the seed and series-a stages.

Which geographies does 321Catalyst focus on?

321Catalyst focuses on Asia, Europe, Global and United States, and is headquartered in United States.